< Back to Article

Rational discovery of dual-indication multi-target PDE/Kinase inhibitor for precision anti-cancer therapy using structural systems pharmacology

Table 1

Top 20 ranked putative off-targets of PDE3B.

Docking score that is less than -7.5 is highlighted in bold.

doi: https://doi.org/10.1371/journal.pcbi.1006619.t001